|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.71 BRL | -6.06% |
|
+0.52% | -40.95% |
| 05-08 | Transcript : Blau Farmacêutica S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| 05-07 | Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Blau Farmacêutica S.A. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was BRL 258.2 million compared to BRL 313.34 million a year ago. Net income was BRL 51.95 million compared to BRL 61.46 million a year ago.
Basic earnings per share from continuing operations was BRL 0.2921 compared to BRL 0.34 a year ago. Diluted earnings per share from continuing operations was BRL 0.2921 compared to BRL 0.34 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -40.95% | 317M | |
| +55.29% | 815B | |
| +45.28% | 654B | |
| -6.88% | 354B | |
| +21.44% | 337B | |
| +10.21% | 302B | |
| +17.75% | 247B | |
| +2.13% | 229B | |
| +12.85% | 219B | |
| +9.73% | 171B |
BLAU FARMACÊUTICA S.A. 
